Clinical Trial Update: A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial evaluating the safety and effects of Felzartamab in adults with lupus nephritis, sponsored by HI-Bio (a Biogen co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Felzartamab (felzartamab)

Snippet

Sponsor: HI-Bio, A Biogen Company | Conditions: Lupus Nephritis | Phase 1 | Status: ACTIVE_NOT_RECRUITING